Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Details)

v3.21.1
Commitments and Contingencies - Additional Information (Details) - Sublease Agreement
$ in Millions
1 Months Ended 3 Months Ended
Sep. 30, 2020
USD ($)
ft²
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Loss Contingencies [Line Items]      
Security deposit   $ 0.9 $ 0.9
Five Prime Therapeutics, Inc. (the "Sublessor")      
Loss Contingencies [Line Items]      
Area of Sublease Premises | ft² 115,466    
Operating lease, expense $ 1.1 $ 1.1  
Lease expiration Date Dec. 31, 2027    
Aggregate estimated base rent payments due, sublease $ 45.5    
Lease base rent abatement $ 5.2    
Initial Premises | Five Prime Therapeutics, Inc. (the "Sublessor")      
Loss Contingencies [Line Items]      
Area of Sublease Premises | ft² 85,755    
Expansion Premises | Five Prime Therapeutics, Inc. (the "Sublessor")      
Loss Contingencies [Line Items]      
Area of Sublease Premises | ft² 29,711